Decoding Innovation: Can OpenAI, Claude, Gemini, or DeepSeek Lead the Way in Drug Discovery

VIDRAFT’s Open Discovery Challenge Surpasses 2,000 Molecule Submissions in Three Days, with Claude Leading Early Results and Chinese Open Models Rivaling OpenAI